NCT06151457View on ClinicalTrials.gov

90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Adverse Effect
Interventions
DRUG

Alpha-Agonist

An initial infusion dose of prophylactic norepinephrine (0.05 ug/kg/min) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 0.01 ug/kg/min of prophylactic norepinephrine according to the responses of previous patients according to the up-down sequential allocation.

DRUG

α-adrenergic receptor agonist

An initial infusion dose of prophylactic norepinephrine (0.05 ug/kg/min) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 0.01 ug/kg/min of prophylactic norepinephrine according to the responses of previous patients according to the up-down sequential allocation.

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER

NCT06151457 - 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients | Biotech Hunter | Biotech Hunter